EcoDrugPlus

Ribosomal Protein L28

Ensembl ID : ENSLCAG00010002317
Gene Symbol: RPL28
1 Cross references
284 Possible Orthologues:

Ribosomal Protein L29

Ensembl ID : ENSLCAG00010014019
Gene Symbol: LOC108891059
4 Cross references
495 Possible Orthologues:

Ribosomal Protein L3

Ensembl ID : ENSLCAG00010014910
Gene Symbol: RPL3
1 Cross references
335 Possible Orthologues:

Ribosomal Protein L30

Ensembl ID : ENSLCAG00010014192
Gene Symbol: LOC108898189
4 Cross references
415 Possible Orthologues:

Ribosomal Protein L31

Ensembl ID : ENSLCAG00010027148
Gene Symbol: LOC108873002
4 Cross references
651 Possible Orthologues:

Ribosomal Protein L32

Ensembl ID : ENSLCAG00010015536
Gene Symbol: RPL32
2 Cross references
236 Possible Orthologues:

Ribosomal Protein L34

Ensembl ID : ENSLCAG00010017061
Gene Symbol: LOC108892844
4 Cross references
362 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSLCAG00010022289
Gene Symbol: LOC108902918
4 Cross references
452 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSLCAG00010002333
Gene Symbol: LOC108874034
4 Cross references
424 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSLCAG00010014254
Gene Symbol: LOC108876502
4 Cross references
193 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSLCAG00010025073
Gene Symbol: RPL39
1 Cross references
143 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSLCAG00010014736
Gene Symbol: RPL39
1 Cross references
85 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).